POET Technologies Surges 115% on a $500 Million AI Deal

POET Technologies, a maker of optical components, saw its stock surge over 115 percent in a single week after announcing a five-year, $500 million supply agreement with Lumilens Inc., signaling a high-stakes bid to capture a piece of the booming AI data center market.

"This new EOI platform will allow us to jointly bring semiconductor-style manufacturing discipline to optical engines — delivering precision, scalability, and cost structure advantages that are essential for AI infrastructure at scale," said POET Chairman and CEO Suresh Venkatesan.

The deal includes an initial $50 million purchase order, with engineering samples planned for late 2026. To facilitate the partnership, POET granted Lumilens warrants to purchase over 22.9 million shares at $8.25 each. The stock's ascent to $20.57 contrasts sharply with its trailing revenue of just $1.1 million and a reported Q1 net loss of $12.3 million.

The Lumilens deal offers a potential lifeline and a path to scale for POET, which aims to ship over 30,000 optical engines in 2026. However, the company's $291 million accumulated deficit and a recent major order cancellation from Marvell highlight the significant execution risk for investors betting on its role in the $9.8 billion 800G transceiver market.

A Tale of Two Valuations

The market is sharply divided on POET's future. Bulls point to the explosive growth in the 800G transceiver market, projected to grow at a 22.8% compound annual growth rate to $9.8 billion by 2032. If POET can execute its Malaysian volume manufacturing and successfully ramp up its 800G optical engines, its current valuation could seem conservative. The company's bull case scenario points to a potential price of $22.89, representing an 11.28% return from its recent high.

However, the bear case is equally compelling. The company trades at a staggering 2,922 price-to-sales ratio on just $1.1 million in trailing twelve-month revenue. This valuation is stretched, especially for a company with a $291 million accumulated deficit. Adding to the concerns, 24/7 Wall St. has issued a "sell" recommendation with a price target of $10.36, implying a nearly 50% downside. This follows a 47.35% single-day stock plunge on April 23 after Marvell (NASDAQ:MRVL) canceled all purchase orders from Celestial AI, a key partner for POET. The company is also facing multiple securities class action lawsuits with a June 29 lead plaintiff deadline.

The stark contrast between the massive potential of the Lumilens deal and the company's precarious financial and legal standing makes POET a classic high-risk, high-reward play on the AI infrastructure boom. While the company has secured approximately $430 million in cash, its ability to convert its technological promise into profitable revenue remains the central question for investors.

This article is for informational purposes only and does not constitute investment advice.